Product Information
IMATINIB MESYLATE 400 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $2.9484 per EA under NDC 59651024130. Its NADAC has been published 281 times since Feb 10, 2021.
Strength
400 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651024130
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IMATINIB MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA212773On Market Since
7/23/2020
Pharmacological Classes
Price Statistics
The NADAC for IMATINIB MESYLATE 400 MG TAB has been published 281 times since Feb 10, 2021, and over the history we have for it it has declined 45.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.9484 per EA |
|---|---|
| All-time high | $5.4031 (Feb 10, 2021) |
| All-time low | $1.4080 (Aug 23, 2023) |
| 52-week high | $3.2150 |
| 52-week low | $2.6631 |
| Median price | $2.6631 |
| Average price | $2.7464 |
| Largest weekly change | -36.2% (Jul 21, 2021) |
| Weeks tracked | 281 |
| Tracking since | Feb 10, 2021 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IMATINIB MESYLATE 400 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for IMATINIB MESYLATE 400 MG TAB, manufactured by Aurobindo Pharma Limited, is $2.9484 per EA (NDC 59651024130), effective Jun 24, 2026.
How has the price of IMATINIB MESYLATE 400 MG TAB changed over time?
Over the history we have for it, the NADAC for IMATINIB MESYLATE 400 MG TAB has declined 45.4%. It has been tracked across 281 weekly CMS publications since Feb 10, 2021.
What are the highest and lowest recorded NADAC prices for IMATINIB MESYLATE 400 MG TAB?
Since Feb 10, 2021, the NADAC for IMATINIB MESYLATE 400 MG TAB has ranged from a low of $1.4080 (Aug 23, 2023) to a high of $5.4031 (Feb 10, 2021), with a median of $2.6631 per EA.
Are there cheaper alternatives to IMATINIB MESYLATE 400 MG TAB?
5 NADAC-published products share the same active ingredient, strength, and dosage form as IMATINIB MESYLATE 400 MG TAB, but none are currently priced below it.
Who manufactures IMATINIB MESYLATE 400 MG TAB?
IMATINIB MESYLATE 400 MG TAB (NDC 59651024130) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification